European Conference on Human Biomonitoring

November 4th and 5th 2008, Paris

Speakers presentations


(Available in Acrobat format )

Introduction to Conference
Session 1 - Concepts, history and general use
Session 2 - Human biomonitoring in environmental health policy
Session 3 - Added value of human biomonitoring in environmental health
Session 4 - Contribution of research to human biomonitoring
Session 5 - Sustainable organisation of human biomonitoring
Debate
Highlights and conclusions of the conference. Version française
Conference report - Annexes (English version only)


Introduction

Introduction to Conference. Anne-Catherine Viso, European Affairs, InVS.


Session 1 - Concepts, history and general use

Introduction to human biomonitoring and biomarkers. Dr. Ludwine Casteleyn, Center for Human Genetics, University of Leuven, Belgium
Human biomonitoring in the framework of the European Environment and Health Action Plan. Dr. Birgit Van Tongelen, European Commission (DG Environment)
Human biomonitoring in occupational health: lessons for environmental health. Dr. Robert Garnier, Paris Poison Centre, France; Dr. Florence Pillière, INRS, France
Human biomonitoring and reference values, German HBM Commission: mandate and achievements. Prof. Dr. Michael Wilhelm, Ruhr-University Bochum, Germany

BACK TO TOP


Session 2 - Human biomonitoring in environmental health policy

Human biomonitoring in Spain. Dr. Argelia Castaño, CNSA, Institute of Health Carlos III, Spain
Human Biomonitoring in the United Kingdom. Dr. Ovnair Sepai, Health Protection Agency, United Kingdom
The French dioxin and incinerators study. Dr. Nadine Fréry, French Institute for Public Health Surveillance (InVS), France
Human biomonitoring in the Czech Republic. Dr. Milena Cerna, National Institute of Public Health, Czech Republic
A case study of the health impacts in an abandoned lead mining area using children's blood lead levels. Dr. Carrie Garavan, Environmental Protection Agency, Ireland
Human Biomonitoring in Cyprus: Cotinine in children - the impact of smoking. Dr. Stella Canna-Michaelidou, State General Laboratory, Ministry of Health, Cyprus
Biomonitoring in Flanders: assessing exposure in the general population and in hot spot areas. Dr. Elly Den Hond, Flemish Institute for Technological Research (VITO), Belgium
The Swedish national health related environmental monitoring programme. Dr. Marika Berglund, Karolinska Institute, Sweden
The German Environmental Survey (GerES). Dr. Marike Kolossa-Gehring, Federal Environment Agency (UBA), Germany

BACK TO TOP


Session 3 - Added value of human biomonitoring in environmental health

Use of biomarkers as exposure measures in the National Children's Study. Dr. Michael Dellarco, National Institute of Child Health and Human Development, USA
Human biomonitoring as a tool to explore exposure patxhways. PD Dr. med. Ursel Heudorf, Public Health Department of the City of Frankfurt, Germany
Chances and limitations of integrating data from human and environmental monitoring at national level. Mr. Jan Koschorreck, Federal Environment Agency (UBA), Germany
Chances and limitations of integrating data from human and environmental monitoring at EU level. Dr. Roel Smolders, Flemish Institute for Technological Research (VITO), Belgium
From science to policy: translation of human biomonitoring results into policy measures in Flanders. Dr. Caroline Teughels, Department of Environment, Nature and Energy, Flemish Government, Belgium
Human environmental biomonitoring as a policy lever: a case study of mercury and pesticide exposures in New York City. Mr. Daniel Kass, New York City Department of Health, USA
The added value of HBM for human health protection: from science to industry action. Ms. Loredana Ghinea, European Chemical Industry Council (Cefic)
Using biomonitoring to raise awareness for policy change – public interest campaigns. Dr. Lisette van Vliet, Health and Environment Alliance (HEAL) and Dr. Sharyle Patton, Commonweal
Communication and Ethics in human biomonitoring. Dr. Birgit Dumez, Centre for Human Genetics, University of Leuven, Belgium
Environmental justice and interpretation of human biomonitoring results. Prof. Dr. Claudia Hornberg, School of Public Health, University Bielefeld, Germany

BACK TO TOP


Session 4 - Contribution of research to human biomonitoring

Overview of EU research projects related to human biomonitoring. Dr. Tuomo Karjalainen, European Commission (DG Research)
Pesticide exposure of pregnant women in Brittany: the Pelagie cohort study. Dr. Cécile Chevrier, Inserm U625, Rennes, France
European mother child cohort studies. Prof. Lisbeth E. Knudsen, PhD, Institute of Public Health, University of Copenhagen, Denmark
Impact of air pollution on biomarkers of genetic damage. Dr. Radim Sram, Institute of Experimental Medicine, Czech Republic
Analytical validation of biomarkers: laboratory issues. Dr. Holger M. Koch, Research Institute of Occupational Medicine (BGFA), Germany
Biomarkers of estrogenic/androgenic activity in connection to breast cancer: an experience from Andalucía. Dr. Nicolás Olea Serrano, Granada University, Spain
Use of biomonitoring data to improve advanced risk assessment models. Dr. Frédéric Y. Bois, INERIS, France

BACK TO TOP


Session 5 - Sustainable organisation of human biomonitoring

Framework for a European Pilot Study. Dr. Reinhard Joas, BiPRO GmbH, Germany
The current activities of JRC in human biomonitoring. Dr. Claude Guillou, Joint Research Centre (European Commission)
The European Health Examination Survey and Human Biomonitoring. Dr. Antoni Montserrat Moliner, European Commission (DG Sanco)
Potential use of human biomonitoring for Reach. Ms. Christiane Heiss, Federal Environment Agency (UBA), Germany
Overview on European specimen banking activities: taking the past into the future. Dr. Andreas Gies, Federal Environment Agency (UBA), Germany
Biomonitoring of environmental chemicals in the Canadian Health Measures Survey. Mr. Douglas Haines, Chemicals Management Directorate, Health Canada, Canada
Public health impact of biomonitoring studies in the United States. Dr. Larry L. Needham, Centres for Disease Control, USA
Human biomonitoring in the Slovenian Chemical Act. Dr. Lijana Kononenko, National Chemicals Bureau, Ministry of Health, Slovenia. Dr. Milena Horvat, Institute Jožef Stefan, Slovenia
The 2003 Flemish Parliament Act on preventive health policy. Dr. Hana Chovanova, Flemish Agency for Care and Health, Belgium
Stockholm Convention and WHO Milk Survey. Dr. Seongsoo Park, World Health Organization
Requirements for a European Human Biomonitoring programme for priority assessment of environmental chemicals. Prof. Matti Jantunen, Prof. Terttu Vartiainen, Dr. Hannu Kiviranta, National Public Health Institute (KTL), Department of Environnemental Health, Kuopio, Finland

BACK TO TOP


Debate

The use and added value of human biomonitoring in environmental health policy. How to create a performant system at european and national level that produces (comparable) data that is relevant for policymakers.

BACK TO TOP


Highlights and conclusions of the conference

Conference report - Annexes


Programme (English and French version)

 

 

Download Acrobat Reader

Back

 


Institut de veille sanitaire
Mise en ligne le 4 décembre 2008
Mise à jour le 23 décembre 2009

CONTACTS Contactez l'InVS